May 27, 2021 – DIA 2021 is a global annual event scheduled between June 27 – July 1 will see esteemed guests, panelists, and speakers at various forums related to drug information.
Xybion Corporation’s Chief Operating Officer, Kamal Biswas will be session chair on Thursday, July 1 at 2:00 pm EDT. The key forum topic is – Predictive Compliance, Risk and Quality Management Transformation: Will your Data Hold up to a Data Integrity Inspection?
Kamal will be joined by the industry experts from the industry as Panelists: Andrew Fisher, Senior GCP Inspector at MHRA; Cheryl Grandinetti, OSI Reviewer at CDER / FDA; Jane von Kirchbach, Vice President, Pfizer Digital, and Sherri Ann Hubby, Senior Director, Clinical QA at Myovant Sciences.
Head of Quality Assurance
Heidi leads Xybion’s Quality Assurance practice. She has over 20 years’ experience in designing and implementing quality assurance policies. Since joining Xybion in 2000, Heidi worked with several clients to design quality policies and ensure compliance. She is responsible to hosting Xybion customer audits. Heidi has a BA degree in Biology from The King’s College.